Announced
Completed
Financials
Sources
Tags
Acquisition
Singapore
Private Equity
Pharmaceuticals
Friendly
Domestic
Majority
Completed
Single Bidder
pharmaceutical
Private
Synopsis
The Sylvan Group, a private investment firm, completed the acquisition of Juniper Biologics, Artemis Health Ventures, DX Imaging and Juniper Therapeutics, four healthcare and pharmaceutical firms, for $141m. "We are investing into mid-size companies that either have strong potential social impact through their businesses or could improve much more by changing their value chains or have solutions for social and environmental problems," Kyungsun Chung, Sylvan Co-Founder and Managing Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.